More News

14 Nov 2017 Excision BioTherapeutics Exclusively Licenses New CRISPR-Cas Gene Editors from UC Berkeley, to be Used for Viral Infections
14 Nov 2017 Homology Medicines and Novartis Enter Collaboration to Develop New Treatments Using Homology's Proprietary Gene Editing Technology
13 Nov 2017 Zymeworks Announces License Agreement with Johnson & Johnson Innovation to Develop and Commercialize Next Generation Bispecific Antibody Therapeutics
13 Nov 2017 Arcus Biosciences Announces $107 Million Series C Financing Led by GV and Initiation of Two Clinical Trials
13 Nov 2017 CRISPR Therapeutics and Casebia Collaborate with CureVac on mRNA for Gene-Editing Programs
09 Nov 2017 Ionis Licenses Novel Antisense Drug for the Treatment of Centronuclear Myopathy to Dynacure
09 Nov 2017 Sanofi, Principia agree to develop multiple sclerosis drug candidate
09 Nov 2017 Neurimmune Announces Collaboration With Ono Pharmaceutical in Neurodegenerative Diseases Field
08 Nov 2017 Boehringer Ingelheim and MiNA Therapeutics to Develop Novel Treatment Approaches for Fibrotic Liver Diseases
08 Nov 2017 CERENIS Therapeutics Acquires LYPRO Biosciences Expanding Its HDL Strategy Into Immuno-Oncology and Chemotherapeutic Drug Delivery
07 Nov 2017 NousCom Raises €42 Million Series B Financing
06 Nov 2017 Collaboration project agreement between MAB Discovery GmbH and BioNTech AG
03 Nov 2017 iPharma Enters Into Licensing Agreement With Boehringer Ingelheim to Obtain Worldwide Rights to FAK Inhibitor Oncology Development Program
03 Nov 2017 Novartis and Amgen announce expanded collaboration with Banner Alzheimer's Institute in pioneering prevention program
02 Nov 2017 Mallinckrodt to Acquire Ocera Therapeutics and OCR-002, its Proprietary Therapy in Development for Treatment of Hepatic Encephalopathy
02 Nov 2017 Boehringer Ingelheim and Dicerna Announce Collaboration to Develop Novel Treatments for Chronic Liver Diseases including Nonalcoholic Steatohepatitis (NASH)
02 Nov 2017 AvidBiotics Splits into Two Biotechnology Companies Each Developing its Distinct Technology Platform
01 Nov 2017 Moderna Announces New Collaboration with AstraZeneca to Co-Develop and Co-Commercialize Relaxin mRNA Therapeutic for Heart Failure
01 Nov 2017 MilliporeSigma and Samsung BioLogics to Extend Strategic Alliance
31 Oct 2017 Kogenix Licenses Gene Therapy for Prevention of Age-Related Dementia and Alzheimer's
31 Oct 2017 Arcturus Therapeutics and Synthetic Genomics Announce Strategic Alliance to Develop Next-Generation Vaccines and Therapeutics
31 Oct 2017 Sarepta Therapeutics Signs Exclusive Global Collaboration with Duke University for Gene Editing CRISPR/Cas9 Technology to Develop New Treatments for Duchenne Muscular Dystrophy (DMD)
31 Oct 2017 Voyager Therapeutics Announces Update to Parkinson’s Disease Program
31 Oct 2017 AstraZeneca and Incyte enter clinical trial collaboration in early lung cancer
30 Oct 2017 Xynomic Pharma Acquires Global Rights of Boehringer Ingelheim's BI 882370, a Novel and Potent RAF Inhibitor against Solid Tumors

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing